The global immune health supplements market, valued at roughly USD 27–35 billion in 2023–2024, is projected to reach over USD 75 billion by 2033, growing at a CAGR of 7% to over 10%. Growth is driven by heightened awareness of preventative health, an aging population, and demand for vitamins (C, D), zinc, and probiotics.
Supplement consumers are changing the market with 2 in 3 global customers now believing they can manage their own health. This is leading to higher adoption of daily immunity-boosting routines. The aging population is driving a massive demand for immune strengthening formulas that resist the natural decline of the immune system.
Supplements in capsule and tablet form remain the dominant format; however, with “pill fatigue” growing a demand for convenience in a drinkable delivery method is increasing. There is a substantial market for stick pack formulas that easily blend with water or individual gel pack formulations that are ready to go and carry.